June 16, 2023
January 25, 2025
This week’s newsletter included:
-
Denali, Alucent Present to Utah Life Sciences Innovation Caucus
-
Myriad Genetics Announces Research Collaboration to Use Minimal Residual Disease Testing Platform
-
Kuda Therapeutics Success Story Highlighted by Utah Innovation Center
-
Utah Business Announces 2023 CXOs of the Year
-
CancerVax Reports Positive Progress on Kids Cancer Immunotherapy Treatment
-
Purgo Scientific Named as One of 61 Startups in MedTech Accelerator 2023 Cohort
-
Recursion’s Phase 2 Trial for Treatment of Cerebral Cavernous Malformation Has Fully Enrolled
-
Acadia Pharmaceuticals Announces Phase 3 Development Candidate ACP-101 (Intranasal Carbetocin) for Prader-Willi Syndrome
-
Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2023
-
CSBI Releases 2023 Life Sciences Workforce Trends Report
-
New Report Explores Best Practices in State Bioscience Economic Development
-
Ampleo Offers New Services – Fractional CMO
Recent News
- bioMérieux strengthens its next-generation sequencing capabilities with the acquisition of Day Zero Diagnostics solutions and technologies
- DGENTHERA AND NUSANO SIGN LETTER OF INTENT FOR ASTATINE‑211 SUPPLY
- 2025 BIO International Recap
- Halia Therapeutics Completes First-in-Human Phase 1 Study of HT-4253, a Novel LRRK2 Inhibitor Targeting Neuroinflammation
- Nelson Labs to Double Cleanroom Capacity to Support Growing Demand for Sterility Assurance Services
- RATIO THERAPEUTICS AND NUSANO ENTER LONG-TERM, MULTI-ISOTOPE SUPPLY AGREEMENT TO BOOST PRODUCTION OF CANCER RADIOPHARMACEUTICALS
